CHIMÄRES ENDOLYSIN-POLYPEPTID

European patent · EP4138883 · In force

Register entry

Publication number
EP4138883
Application number
EP21717923
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 16, 2021
Published
Mar 1, 2023
Granted
Sep 10, 2025
Protection ends at the latest
Apr 15, 2041
Next annual fee due
Apr 30, 2027
IPC classes
C07K 14/31 (2006.01)
C12N 9/50 (2006.01)
A61K 38/00 (2006.01)
A61K 38/47 (2006.01)
Priority
EP 20170432 20.04.2020
PCT application
PCT/EP2021/059849 16.04.2021
PCT publication
WO2021/213898 28.10.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 22, 2026

    Change

    Published in Swissreg on 22.07.2026

  2. May 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.04.2026 → 30.04.2027

    Published in Swissreg on 01.05.2026

  3. Sep 10, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.09.2025

Parties

Holder

Micreos Human Health B.V.

Bankaplein 2, 2585 EV Den Haag, NL

Inventor

EICHENSEHER, Fritz

2585 EV Den Haag, NL

SCHMELCHER, Mathias

2585 EV Den Haag, NL

RÖHRIG, Christian Alexander

2585 EV Den Haag, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.